iotaSciences Presents First Encouraging Data for Use of New isoPick™ Single-Cell Picker

iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, announced today the first encouraging data for the use of its recently launched single-cell picking instrumentation isoPick™ based on the company´s proprietary fluid-shaping technology. In a collaboration with SEISMIC at the University of Surrey, the isoPick™ has been evaluated for single-cell sampling for subsequent analysis by mass spectrometry. Notably, the isoPick™ came out strongly against several aspects related to ease of use, portability and automation. The results of the evaluation study will be presented as a poster presentation at the upcoming British Mass Spectrometry Society (BMSS) annual meeting in Manchester (UK) from September 12-14, 2023.

Professor Melanie Bailey from the Department of Chemistry at the University of Surrey said: "We have been pleased with the recent comparative performance of the isoPick™ instrument in our attempt to develop methods for mass spectrometry-based analysis of single cells. We look forward to further collaboration with iotaSciences while we develop a facility for single-cell and sub-cellular "omics" and to support UK academics and industry researchers working in BBSRC (Biotechnology and Biological Sciences Research Council) remit areas."

IotaSciences’ Chief Product Officer Alexander Feuerborn commented: "We are extremely excited about this first encouraging set of data for the isoPick™ instrument for mass spectrometric analysis of single cells. These results strongly confirm our original intentions to introduce a high-quality, precise and robust single-cell picking instrument with an easy-to-use end-to-end solution for verifiable isolation and subsequent analysis of single cells. For us, this clearly opens the wider application space in the fields of single-cell proteomics and lipidomics."

In September 2023, iotaSciences will showcase its full fleet of powerful single-cell handling technologies at the upcoming 11th International Heidelberg Symposium on Stem Cells and Cancer - SCC2023 (Germany) and the German Stem Cell Network conference in Ulm (Germany).